NCT00677001View on ClinicalTrials.gov

A Research Study to Evaluate the Safety of R306465, a Drug in Development for Cancer and to Study the Absorption, Break Down and Elimination in Patients With Advanced Solid Malignancies.

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 30, 2005

Study Completion Date

October 31, 2006

Conditions
Neoplasms
Interventions
DRUG

R306465

All Listed Sponsors
collaborator

Janssen-Cilag Ltd.

INDUSTRY

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00677001 - A Research Study to Evaluate the Safety of R306465, a Drug in Development for Cancer and to Study the Absorption, Break Down and Elimination in Patients With Advanced Solid Malignancies. | Biotech Hunter | Biotech Hunter